Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients.

Patient preference and adherence

Luymes CH, Boelhouwer NJ, Poortvliet RK, de Ruijter W, Reis R, Numans ME.
PMID: 28579760
Patient Prefer Adherence. 2017 May 23;11:975-984. doi: 10.2147/PPA.S131625. eCollection 2017.

BACKGROUND: Patients with low cardiovascular disease (CVD) risk potentially use preventive cardiovascular medication unnecessarily. Our aim was to identify various viewpoints and beliefs concerning the preventive CVD management of patients with low CVD risk using preventive cardiovascular medication. Furthermore,...

Cite
Luymes CH, Boelhouwer NJ, Poortvliet RK, et al. Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients. Patient Prefer Adherence. 2017;11:975-984doi: 10.2147/PPA.S131625.
Luymes, C. H., Boelhouwer, N. J., Poortvliet, R. K., de Ruijter, W., Reis, R., & Numans, M. E. (2017). Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients. Patient preference and adherence, 11975-984. https://doi.org/10.2147/PPA.S131625
Luymes, Clare H, et al. "Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients." Patient preference and adherence vol. 11 (2017): 975-984. doi: https://doi.org/10.2147/PPA.S131625
Luymes CH, Boelhouwer NJ, Poortvliet RK, de Ruijter W, Reis R, Numans ME. Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients. Patient Prefer Adherence. 2017 May 23;11:975-984. doi: 10.2147/PPA.S131625. eCollection 2017. PMID: 28579760; PMCID: PMC5449103.
Copy Download .nbib Format: NLM
Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin.

Medical journal of the Islamic Republic of Iran

Pordal AH, Hajmiresmail SJ, Assadpoor-Piranfar M, Hedayati M, Ajami M.
PMID: 26157710
Med J Islam Repub Iran. 2015 Mar 14;29:192. eCollection 2015.

BACKGROUND: Considering the increasing incidence of coronary artery stenosis and its related complications, the importance of its etiology and inconsistent reports we aimed to determine the relationship between oxysterol, serum levels and severity of coronary atherosclerosis and effect of...

Cite
Pordal AH, Hajmiresmail SJ, Assadpoor-Piranfar M, et al. Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin. Med J Islam Repub Iran. 2015;29:192
Pordal, A. H., Hajmiresmail, S. J., Assadpoor-Piranfar, M., Hedayati, M., & Ajami, M. (2015). Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin. Medical journal of the Islamic Republic of Iran, 29192.
Pordal, Amir-Hamzeh, et al. "Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin." Medical journal of the Islamic Republic of Iran vol. 29 (2015): 192.
Pordal AH, Hajmiresmail SJ, Assadpoor-Piranfar M, Hedayati M, Ajami M. Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin. Med J Islam Repub Iran. 2015 Mar 14;29:192. eCollection 2015. PMID: 26157710; PMCID: PMC4476218.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries